Ab Rahman Noor Iftitah, Yunos Nor'azim Mohd, Atan Rafidah, Mariapun Jeevitha, Ab Rahman Mohd Ali'Imran, Ismail Abdul Jabbar, Deva Shanti Rudra
Department of Anaesthesiology, Faculty of Medicine, Universiti Malaya Medical Centre, Universiti Malaya, Kuala Lumpur, Malaysia.
Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Malaysia.
Front Med (Lausanne). 2023 Jan 9;9:1086288. doi: 10.3389/fmed.2022.1086288. eCollection 2022.
BACKGROUND: Coronavirus disease 2019 (COVID-19) emerged with a wide range of clinical presentations; Malaysia was not spared from its impact. This study describes the clinical characteristics of COVID-19 patients admitted to intensive care unit, their clinical course, management, and hospital outcomes. METHODS: COVIDICU-MY is a retrospective analysis of COVID-19 patients from 19 intensive care units (ICU) across Malaysia from 1 March 2020 to 31 May 2020. We collected epidemiological history, demographics, clinical comorbidities, laboratory investigations, respiratory and hemodynamic values, management, length of stay and survival status. We compared these variables between survival and non-survival groups. RESULTS: A total of 170 critically ill patients were included, with 77% above 50 years of age [median age 60, IQR (51-66)] and 75.3% male. Hypertension, diabetes mellitus, hyperlipidemia, chronic cardiac disease, and chronic kidney disease were most common among patients. A high Simplified Acute Physiology Score (SAPS) II score [median 45, IQR (34-49)] and Sequential Organ Failure Assessment (SOFA) score [median 8, IQR (6-11)] were associated with mortality. Patients were profoundly hypoxic with a median lowest PaO/FiO ratio of 150 (IQR 99-220) at admission. 91 patients (53.5%) required intubation on their first day of admission, out of which 38 died (73.1% of the hospital non-survivors). Our sample had more patients with moderate Acute Respiratory Distress Syndrome (ARDS), 58 patients (43.9%), compared to severe ARDS, 33 patients (25%); with both ARDS classification groups contributing to 25 patients (54.4%) and 11 patients (23.9%) of the non-survival group, respectively. Cumulative fluid balance over 24 h was higher in the non-survival group with significant differences on Day 3 (1,953 vs. 622 ml, < 0.05) and Day 7 of ICU (3,485 vs. 830 ml, < 0.05). Patients with high serum creatinine, urea, lactate dehydrogenase, aspartate aminotransferase and d-dimer, and low lymphocyte count throughout the stay also had a higher risk of mortality. The hospital mortality rate was 30.6% in our sample. CONCLUSION: We report high mortality amongst critically ill patients in intensive care units in Malaysia, at 30.6%, during the March to May 2020 period. High admission SAPS II and SOFA, and severe hypoxemia and high cumulative fluid balance were associated with mortality. Higher creatinine, urea, lactate dehydrogenase, aspartate aminotransferase and d-dimer, and lymphopenia were observed in the non-survival group.
背景:2019冠状病毒病(COVID-19)出现时伴有多种临床表现;马来西亚也未能幸免其影响。本研究描述了入住重症监护病房的COVID-19患者的临床特征、临床病程、治疗及医院结局。 方法:COVIDICU-MY是一项对2020年3月1日至2020年5月31日期间马来西亚19个重症监护病房(ICU)的COVID-19患者进行的回顾性分析。我们收集了流行病学史、人口统计学资料、临床合并症、实验室检查、呼吸和血流动力学值、治疗、住院时间和生存状况。我们比较了生存组和非生存组之间的这些变量。 结果:共纳入170例危重症患者,77%年龄在50岁以上[中位年龄60岁,四分位间距(IQR)(51-66)],75.3%为男性。高血压、糖尿病、高脂血症、慢性心脏病和慢性肾脏病在患者中最为常见。高简化急性生理学评分(SAPS)II评分[中位值45,IQR(34-49)]和序贯器官衰竭评估(SOFA)评分[中位值8,IQR(6-11)]与死亡率相关。患者入院时严重缺氧,最低动脉血氧分压/吸入氧分数值(PaO/FiO)中位数为150(IQR 99-220)。91例患者(53.5%)在入院第一天需要插管,其中38例死亡(占医院非幸存者的73.1%)。与重度急性呼吸窘迫综合征(ARDS)患者33例(25%)相比,我们的样本中中度ARDS患者更多,有58例(43.9%);两个ARDS分类组分别占非生存组患者的25例(54.4%)和 11例(23.9%)。非生存组24小时累积液体平衡量更高,在ICU第3天(1953 vs. 622 ml,P< 0.05)和第7天(3485 vs. 830 ml,P< 0.05)有显著差异。整个住院期间血清肌酐、尿素、乳酸脱氢酶、天冬氨酸氨基转移酶和D-二聚体水平高且淋巴细胞计数低的患者死亡风险也更高。我们样本中的医院死亡率为30.6%。 结论:我们报告了2020年3月至5月期间马来西亚重症监护病房危重症患者的高死亡率,为30.6%。高入院SAPS II和SOFA评分、严重低氧血症和高累积液体平衡与死亡率相关。非生存组观察到肌酐、尿素、乳酸脱氢酶、天冬氨酸氨基转移酶和D-二聚体水平更高,且存在淋巴细胞减少。
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020-9
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018-10
Lancet Reg Health West Pac. 2020-11